Abstract
Purpose
Current knowledge about the ovarian reserve in patients with type 1 diabetes is inconsistent and based on studies with small sample size. This meta-analysis aimed to produce a comprehensive evaluation on the ovarian reserve of type 1 diabetes female patients and to analyze the associated factors with the ovarian reserve.
Methods
Systematic searches were conducted for studies published from the inception to December 2021. Original human observational studies either with case-control, cross-sectional, or longitudinal design evaluating ovarian reserve markers between type 1 diabetes patients and healthy controls were included. Levels of anti-müllerian hormone (AMH), follicle-stimulating hormone (FSH), and estradiol (E2) were extracted.
Results
It was indicated that women with type 1 diabetes were associated with decreased levels of AMH compared with healthy controls (weighted mean difference [WMD] −0.70 ng/ml, 95% confidence intervals [CI] −1.05 to −0.34 ng/ml, P = 0.0001). Subgroup analyses stratified by age showed that adult patients with type 1 diabetes were associated with decreased levels of AMH (WMD −0.70 ng/ml, 95% CI −1.06 to −0.34 ng/ml, P = 0.0001) and FSH (WMD −1.07 IU/L, 95% CI −1.75 to −0.39 IU/L, P = 0.002) compared with healthy controls. Meta-regression analysis showed no significant correlation between AMH, FSH, and clinical factors, while level of E2 was negatively correlated with daily insulin doses and glycosylated hemoglobin A1c (HbA1c) values.
Conclusion
According to this meta-analysis, type 1 diabetes might be associated with decreased AMH levels. Further studies using different markers and fertility outcomes focus on the ovarian reserve of women with type 1 diabetes are urgently needed.
Similar content being viewed by others
References
S.U. Park, L. Walsh, K.M. Berkowitz, Mechanisms of ovarian aging. Reproduction 162, R19–33 (2021)
H. Xu, M. Zhang, H. Zhang, H. Zhang, K. Alpadi, K.L. Wang, R. Li, J. Qiao, Clinical applications of serum anti-müllerian hormone measurements in both males and females: an update. Innovation 9, 100091 (2021)
L.M.E. Moolhuijsen, J.A. Visser, Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function. J. Clin. Endocrinol. Metab. 105, 3361–3373 (2020)
D.B. Seifer, G. Lambert-Messerlian, J.W. Hogan, A.C. Gardiner, A.S. Blazar, C.A. Berk, Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 67, 110–114 (1997)
F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, C.B. Lambalk, A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 12, 685–718 (2016)
S.L. Broer, J. van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, P. Bossuyt, M.J. Eijkemans, B.W. Mol, F.J. Broekmans; IMPORT study group, Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum. Reprod. Update 19, 26–36 (2013)
A. Lass, J. Skull, E. McVeigh, R. Margara, R.M. Winston, Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in vitro fertilization can predict poor response. Hum. Reprod. 12, 294–297 (1997)
International Diabetes Federation, IDF Diabetes Atlas, 9th ed. https://diabetesatlas.org/atlas/ninth-edition/. Accessed 1 Feb 2021.
K. Kjaer, C. Hagen, S.H. Sandø, O. Eshøj, Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J. Clin. Endocrinol. Metab. 75, 524–529 (1992)
K.K. Danielson, M. Palta, C. Allen, D.J. D’Alessio, The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J. Clin. Endocrinol. Metab. 90, 6466–6471 (2005)
J.S. Dorman, A.R. Steenkiste, T.P. Foley, E.S. Strotmeyer, J.P. Burke, L.H. Kuller, C.K. Kwoh, Menopause in type 1 diabetic women: is it premature? Diabetes 50, 1857–1862 (2001)
N. Soto, G. Iñiguez, P. López, G. Larenas, V. Mujica, R.A. Rey, E. Codner, Anti-müllerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum. Reprod. 24, 2838–2844 (2009)
C. Kim, C. Karvonen-Gutierrez, S. Kong, V. Arends, M. Steffes, D.S. McConnell, J.F. Randolph Jr, S.D. Harlow, Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study. Fertil. Steril. 106, 1446–1452 (2016)
F. Yarde, W. Spiering, A. Franx, F.L.J. Visseren, M.J.C. Eijkemans, H.W. de Valk, F.J.M. Broekmans; OVADIA Study Group, Association between vascular health and ovarian ageing in type 1 diabetes mellitus. Hum. Reprod. 31, 1354–1362 (2016)
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009)
Rostom, A., Dubé, C., Cranney, A., Saloojee, N., Sy, R., Garritty, C., Sampson, M., Zhang, L., Yazdi, F., Mamaladze, V., Pan, I. McNeil, J., Moher, D., Mack, D., Patel, D. Celiac disease. Evid. Rep. Technol. Assess. 104, 1–6 (2004).
S.P. Hozo, B. Djulbegovic, I. Hozo, Estimating the mean and variance from the median, range, and the size of a sample. Bmc. Med. Res. Methodol. 5, 13 (2005)
V. Calcaterra, R.E. Nappi, G. Pelizzo, A. De Silvestri, R. Albertini, M. De Amici, E. Tenuta, F. Vinci, C. Mameli, G. Zuccotti, Insulin resistance and potential modulators of ovarian reserve in young reproductive-aged women with obesity and type 1 diabetes. Gynecol. Endocrinol. 37, 823–830 (2021)
E. Codner, D. Mook-Kanamori, R.A. Bazaes, N. Unanue, H. Sovino, F. Ugarte, A. Avila, G. Iñiguez, F. Cassorla, Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J. Clin. Endocrinol. Metab. 90, 3939–3945 (2005)
E. Codner, N. Soto, P. Lopez, L. Trejo, A. Avila, F.C. Eyzaguirre, G. Iniguez, F. Cassorla, Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 91, 2250–2256 (2006)
A. Łebkowska, A. Adamska, M. Karczewska-Kupczewska, A. Nikołajuk, E. Otziomek, R. Milewski, M. Górska, S. Wołczyński, I. Kowalska, Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Metabolism 65, 804–811 (2016)
P. Kadiroğulları, E. Demir, P.Y. Bahat, H. Kıyak, K.D. Seckin, Evaluation of relationship between HbA1c levels and ovarian reserve in patients with type 1 diabetes mellitus. Gynecol. Endocrinol. 36, 426–430 (2020)
L.S. Hassan, R.S. Monson, K.K. Danielson, Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls. Diabetes Metab. Res. Rev. 33, 2829 (2017)
R. Tal, D.B. Seifer, Ovarian reserve testing: a user’s guide. Am. J. Obstet. Gynecol. 217, 129–140 (2017)
J.G. Regensteiner, S. Golden, A.G. Huebschmann, E. Barrett-Connor, A.Y. Chang, D. Chyu, C.S. Fox, C. Kim, N. Mehta, J.F. Reckelhoff, J.E.B. Reusch, K.M. Rexrode, A.E. Sumner, F.K. Welty, N.K. Wegner, B. Anton, Sex Differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 132, 2424–2447 (2015)
Practice Committee of the American Society for Reproductive Medicine, Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil. Steril. 103, e9–17 (2015)
Z. Jamil, S.S. Fatima, K. Ahmed, R. Malik, Anti-Müllerian hormone: above and beyond conventional ovarian reserve markers. Dis. Markers 2016, 5246217 (2016)
M. Depmann, M.J. Faddy, Y.T. van der Schouw, P.H.M. Peeters, S.L. Broer, T.W. Kelsey, S.M. Nelson, F.J.M. Broekmans, The relationship between variation in size of the primordial follicle pool and age at natural menopause. J. Clin. Endocrinol. Metab. 100, e845–851 (2015)
M.R. Gohari, F.R. Tehrani, S. Chenouri, M. Solaymani-Dodaran, F. Azizi, Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone. Menopause 23, 839–845 (2016)
A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A.C. Artenisio, G. Stabile, A. Volpe, Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update 16, 113–130 (2010)
F.R. Tehrani, H. Erfani, L. Cheraghi, M. Tohidi, F. Azizi, Lipid profiles and ovarian reserve status: a longitudinal study. Hum. Reprod. 29, 2522–2529 (2014)
N.M. Daan, B.C. Fauser, Menopause prediction and potential implications. Maturitas 82, 257–265 (2015)
M.L. Griffin, S.A. South, V.I. Yankov, R.A. Booth Jr, C.M. Asplin, J.D. Veldhuis, W.S. Evans, Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann. Med. 26, 331–340 (1994)
K. Kjaer, C. Hagen, S. Sando, O. Eshoj, Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulindependent diabetes mellitus compared to control subjects. J. Clin. Endocrinol. Metab. 75, 524–529 (1992)
A. Yeshaya, R. Orvieto, D. Dicker, M. Karp, Z. Ben-Rafael, Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J. Fertil. 40, 269–273 (1995)
A.S. Chang, A.N. Dale, K.H. Moley, Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 146, 2445–2453 (2005)
S.A. Colton, P.G. Humpherso, H.J. Lees, S.M. Downs, Physiological changes in oocyte-cumulus cell complexes from diabetic mice that potentially influence meiotic regulation. Biol. Reprod. 69, 761–770 (2003)
C. Tatone, F. Amicarelli, M.C. Carbone, P. Monteleone, D. Caserta, R. Marci, P.G. Artini, P. Piomboni, R. Focarelli, Cellular and molecular aspects of ovarian follicle ageing. Hum. Reprod. Update 14, 131–142 (2008)
E. Diamanti-Kandarakis, C. Piperi, E. Patsouris, P. Korkolopoulou, D. Panidis, L. Pawelczyk, A.G. Papavassiliou, A.J. Duleba, Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem. Cell. Biol. 127, 581–589 (2007)
M.F. Wellons, J.J. Matthews, C. Kim, Ovarian aging in women with diabetes: an overview. Maturitas 96, 109–113 (2017)
R. Salvi, E. Castillo, M.J. Voirol, M. Glauser, J.P. Rey, R.C. Gailard, P. Vollenweider, F.P. Pralong, Gonadotropin-releasing hormone-expressing neurons immortalized conditionally are activated by insulin: implication of the mitogen-activated protein kinase pathway. Endocrinology 147, 816–826 (2006)
J.C. Brüning, D. Gautam, D.J. Burks, J. Gillette, M. Schubert, P.C. Orban, R. Klein, W. Krone, D. Müller-Wieland, C.R. Kahn, Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000)
J.M. Castellano, V.M. Navarro, J. Roa, R. Pineda, M.A. Sánchez-Garrido, D. García-Galiano, E. Vigo, C. Dieguez, E. Aguilar, L. Pinilla, M. Tena-Sempere, Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 150, 784–794 (2009)
B. Lawrenz, J. Henes, M. Henes, E. Neunhoeffer, M. Schmalzing, T. Fehm, I. Kïtter, Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus 20, 1193–1197 (2011)
W. Luo, P. Mao, L. Zhang, X. Chen, Z. Yang, Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis. Ann. Palliat. Med. 9, 207–215 (2020)
M.E. Clowse, S.C. Copland, T.C. Hsieh, S.C. Chow, G.S. Hoffman, P.A. Merkel, R.F. Spiera, J.C. Davis Jr, W.J. McCune, S.R. Ytterberg, E.W. St Clair, N.B. Allen, U. Specks, J.H. Stone; WGET Research Group, Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener’s). Arthritis Care. Res. 63, 1777–1781 (2011)
C. Betterle, A. Rossi, S.D. Dalla Pria, A. Artifoni, B. Pedini, S. Gavasso, A. Caretto, Premature ovarian failure: autoimmunity and natural history. Clin. Endocrinol. 39, 35–43 (1993)
H.F. Escobar-Morreale, B. Roldán, R. Barrio, M. Alonso, J. Sancho, H. de la Calle, R. García-Robles, High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 85, 4182–4187 (2000)
H.F. Escobar-Morreale, M. Belén Roldán-Martín, Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care 39, 639–648 (2016).
N. Moslehi, S. Shab-Bidar, F.R. Tehrani, P. Mirmiran, F. Azizi, Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause 25, 1046–1055 (2018)
Acknowledgements
The authors would like to thank all the doctors, nurses, and technicians for their practical work during the study at Department of Endocrinology and Metabolism, Peking University People’s Hospital.
Author contributions
X.C. and L.J. conceived and designed the review. W.Y., C.L., F.L., X.Z. identified reports and extracted data. X.C. and X.H. provided statistical advice and contributed to data interpretation. W.Y. drafted the paper. M.Z. helped revised the paper. All authors read and approved the final paper.
Funding
This study was supported by National Natural Science Foundation of China (No. 81903711, 81970698, 81970708) and Beijing Natural Science Foundation (No. 7202216).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Yang, W., Lin, C., Zhang, M. et al. Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis. Endocrine 77, 205–212 (2022). https://doi.org/10.1007/s12020-022-03091-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03091-y